title: [An ergometric cross-over evaluation of the anti-ischemic efficacy of amlodipine and gallopamil in stable angina of effort].
abstract: In the setting of stable effort angina a single-blind, randomized, cross-over study to evaluate the effects of gallopamil (GAL) and amlodipine (AML) on exercise tolerance and ischemic ST depression was conducted. Fifteen outpatients, 12 males and 3 females, aged 40-65 years (57 +/- 9), with documented coronary atherosclerosis and reproducible ST-segment depression on 2 consecutive baseline exercise stress tests, completed the study, which consisted of 4 periods: 1 and 3 placebo, 2 and 4 at random GAL (50 mg tid) and AML (10 mg/daily). At the end of each period a multistage treadmill exercise stress test (Bruce protocol) was performed. Both drugs significantly (p = 0.0001) increased the ischemia time (IT) (0.1 mV ST depression) as compared to placebo, from 416 +/- 165 s to 635 +/- 161 s (GAL) and 607 +/- 152 s (AML) with significant difference (p = 0.2) between the 2 drugs, and reduced significantly (p = 0.001) the maximal ST depression from -0.25 +/- 0.09 mV to -0.11 +/- 0.08 mV (GAL) and -0.12 +/- 0.09 mV (AML). At the IT, the systolic blood pressure increased from 178 +/- 23 mmHg to 185 +/- 20 mmHg (GAL) and remained unchanged during AML treatment (178 +/- 15 mmHg); similarly, the heart rate increased from 126 +/- 22 b/min to 139 +/- 21 b/min (GAL) and 138 +/- 19 b/min (AML). In conclusion, both GAL and AML showed a good anti-ischemic effect (IT = +52.6% during GAL and +45.9% during AML), even if GAL proved to be significantly more effective than AML.
authors.affiliation: Dipartimento di Medicina Sperimentale e Clinica in Catanzaro, Università degli Studi, Reggio Calabria.
authors.forename: F
authors.initials: F
authors.lastname: Perticone
authors.forename: D A
authors.initials: DA
authors.lastname: Borelli
authors.forename: F
authors.initials: F
authors.lastname: Pugliese
authors.forename: R
authors.initials: R
authors.lastname: Maio
authors.forename: R
authors.initials: R
authors.lastname: Costa
authors.forename: C
authors.initials: C
authors.lastname: Cosco
authors.forename: R
authors.initials: R
authors.lastname: Ceravolo
authors.forename: P L
authors.initials: PL
authors.lastname: Mattioli
mesh_terms: D000328:Adult; D000368:Aged; D017311:Amlodipine / Q000009:adverse effects / Q000627:therapeutic use*; D000704:Analysis of Variance; D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005080:Exercise Test / Q000379:methods* / Q000706:statistics & numerical data; D005260:Female; D005711:Gallopamil / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000175:diagnosis / Q000188:drug therapy* / Q000453:epidemiology; D005082:Physical Exertion / Q000187:drug effects*; D016037:Single-Blind Method
chemical_list: D017311:Amlodipine; D005711:Gallopamil
vernacular_title: Valutazione ergometrica in cross-over dell'efficacia antischemica dell'amlodipina e del gallopamil nell'angina stabile da sforzo.